炎症生物标志物与慢性鼻炎与鼻的疾病控制之间的相关性
Eugenio De Corso1, Silvia Baroni2,3, Stefano Settimi1,4
1Unit of Otorhinolaryngology and Head-Neck Surgery, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
International forum of allergy & rhinology
|January 24, 2024
概括
鼻分泌物和组织中的中白素-5 (IL-5) 和calprotectin水平可以帮助识别严重的慢性鼻炎与鼻息肉 (CRSwNP) 患者. 喘和NSAID加重的呼吸道疾病也是不受控制的疾病的关键指标.
科学领域:
- 免疫学 免疫学 免疫学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 呼吸系统医学 呼吸系统医学
背景情况:
- 带鼻息肉的慢性鼻炎 (CRSwNP) 呈现出与内型相关的多种治疗反应.
- 与CRSwNP严重程度相关的生物标志物数据有限.
- 这项研究调查了IL-5和calprotectin作为潜在的严重性和控制生物标志物.
研究的目的:
- 评估IL-5和calprotectin在定义CRSwNP严重性的有用性.
- 确定生物标志物,以区分受控制与不受控制的CRSwNP.
- 为了将生物标志物水平与疾病严重程度和治疗结果相关联.
主要方法:
- 一项涉及81名CRSwNP患者的病例控制研究,他们之前接受过手术,并接受了鼻内类固醇治疗.
- A组包括39名不受控制的患者 (SNOT-22 ≥40);B组包括42名受控制的患者 (SNOT-22 <40).
- 在鼻分泌物和多组织中测量IL-5和calprotectin.
主要成果:
- 在不受控制的CRSwNP患者 (A组) 中,在分泌物和组织中发现显著更高的IL-5和calprotectin水平.
- 增加之前的手术与鼻分泌物中较高的IL-5和calprotectin水平相关.
- 多变量分析确定了喘,NSAID加重的呼吸道疾病 (NSAID-ERD) 和IL-5作为无法控制疾病的显著预测因素.
结论:
- 喘,NSAID-ERD和鼻分泌物/组织中的IL-5是识别严重CRSwNP的有价值指标.
- 在不受控制的患者中观察到高卡尔蛋白蛋白和中性友好水平,特别是那些先前进行过多次手术的患者.
- 这些生物标志物可能有助于个性化CRSwNP的治疗策略.
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
92
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
92
Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
Inflammatory Response
2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K


